Full Text (PDF)
RFP Indian Journal of Medical Psychiatry 3(1):p 45-46, Jaunary–June 2020. | DOI:
Case Report
A Case Report on Risperidone Induced Prolactinoma
Chandrashekhar Venkaraddi Mangannavar , Joann Rebekah Varghese , Ginitha Chacko , Flemin Thomas , Narayan R Mutalik , Chandrashekhar Venkaraddi Mangannavar
Author Information
Licence:
RFP Indian Journal of Medical Psychiatry 3(1):p 45-46, Jaunary–June 2020. | DOI:
How Cite This Article:
Joann Rebekah Varghese, Ginitha Chacko, Flemin Thomas. A Case Report on Risperidone induced Prolactinoma. RFP Indian Journal of Medical Psychiatry. 2020;3(1):45-46
Timeline
Received : N/A
Accepted : N/A
Published : N/A
Abstract
Risperidone is a second generation antipsychotic reported to cause hyperprolactinemia due to its D2 receptor antagonism, which may induce amenorrhea, altered menstrual cycle, loss of libido and increase the long-term risk of osteoporosis. However, to our knowledge, all previous reports have focused on risperidone induced hyperprolactinemia.Here we are presenting a rare case report on prolactinoma caused by risperidone.
Keywords: Risperifone; Adverse Drug reaction; prolactinoma.
References
No records found.
Article Level Metrics
Last UpdatedMonday 26 January 2026, 19:15:26 (IST)
99
Accesses
0
18
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | N/A |
| Accepted | N/A |
| Published | N/A |